Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 354

1.

Development of Transfusion Guidelines for Injured Children Using a Modified Delphi Consensus Process.

Trappey AF 3rd, Thompson KM, Kuppermann N, Stephenson JT, Nuno MA, Hewes HA, Meyers SR, Stanley RM, Galante JM, Nishijima DK.

J Trauma Acute Care Surg. 2019 Jul 9. doi: 10.1097/TA.0000000000002432. [Epub ahead of print] No abstract available.

PMID:
31299040
2.

Logistical challenges and assumptions for modeling the failure of global cessation of oral poliovirus vaccine (OPV).

Thompson KM, Kalkowska DA.

Expert Rev Vaccines. 2019 Jul 2:1-12. doi: 10.1080/14760584.2019.1635463. [Epub ahead of print]

PMID:
31248293
3.

Polio endgame options: will we have the vaccines needed?

Thompson KM.

Lancet. 2019 Jul 13;394(10193):99-100. doi: 10.1016/S0140-6736(19)31294-2. Epub 2019 Jun 4. No abstract available.

4.

Another look at silent circulation of poliovirus in small populations.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM.

Infect Dis Model. 2018 Jun 9;3:107-117. doi: 10.1016/j.idm.2018.06.001. eCollection 2018.

5.

What will it take to end fatalities from measles?

Thompson KM.

Lancet Glob Health. 2019 Apr;7(4):e394-e395. doi: 10.1016/S2214-109X(19)30050-6. Epub 2019 Feb 21. No abstract available.

6.

Characterising the costs of the Global Polio Laboratory Network: a survey-based analysis.

Duintjer Tebbens RJ, Diop OM, Pallansch MA, Oberste MS, Thompson KM.

BMJ Open. 2019 Jan 21;9(1):e023290. doi: 10.1136/bmjopen-2018-023290.

7.

Estimating the Prevalence of United States Women with Alcohol-exposed Pregnancies and Births.

Roberts SCM, Thompson KM.

Womens Health Issues. 2019 Mar - Apr;29(2):188-193. doi: 10.1016/j.whi.2018.11.001. Epub 2019 Jan 13.

PMID:
30651200
8.

Global certification of wild poliovirus eradication: insights from modelling hard-to-reach subpopulations and confidence about the absence of transmission.

Duintjer Tebbens RJ, Kalkowska DA, Thompson KM.

BMJ Open. 2019 Jan 15;9(1):e023938. doi: 10.1136/bmjopen-2018-023938.

9.

Ketamine interactions with gut-microbiota in rats: relevance to its antidepressant and anti-inflammatory properties.

Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y.

BMC Microbiol. 2018 Dec 22;18(1):222. doi: 10.1186/s12866-018-1373-7.

10.

Implementation of Bar-Code Medication Administration to Reduce Patient Harm.

Thompson KM, Swanson KM, Cox DL, Kirchner RB, Russell JJ, Wermers RA, Storlie CB, Johnson MG, Naessens JM.

Mayo Clin Proc Innov Qual Outcomes. 2018 Nov 26;2(4):342-351. doi: 10.1016/j.mayocpiqo.2018.09.001. eCollection 2018 Dec.

11.

The Yersinia pseudotuberculosis Cpx envelope stress system contributes to transcriptional activation of rovM.

Thanikkal EJ, Gahlot DK, Liu J, Fredriksson Sundbom M, Gurung JM, Ruuth K, Francis MK, Obi IR, Thompson KM, Chen S, Dersch P, Francis MS.

Virulence. 2019 Dec;10(1):37-57. doi: 10.1080/21505594.2018.1556151.

12.

Corrigendum to 'Current and past depressive symptoms and contraceptive effectiveness level method selected among women seeking reproductive health services' Social Science and Medicine 2018214: 20-25.

Steinberg JR, Adler NE, Thompson KM, Westhoff C, Harper CC.

Soc Sci Med. 2019 Jan;220:440. doi: 10.1016/j.socscimed.2018.11.020. Epub 2018 Nov 30. No abstract available.

13.

Epstein-Barr virus-specific T cell therapy for progressive multiple sclerosis.

Pender MP, Csurhes PA, Smith C, Douglas NL, Neller MA, Matthews KK, Beagley L, Rehan S, Crooks P, Hopkins TJ, Blum S, Green KA, Ioannides ZA, Swayne A, Aftab BT, Hooper KD, Burrows SR, Thompson KM, Coulthard A, Khanna R.

JCI Insight. 2018 Nov 15;3(22). pii: 124714. doi: 10.1172/jci.insight.124714.

14.

Liposomal bupivacaine mixture has similar pain relief and significantly fewer complications at less cost compared with indwelling interscalene catheter in total elbow arthroplasty.

Thompson KM, Smith RA, Brolin TJ, Azar FM, Throckmorton TW.

J Shoulder Elbow Surg. 2018 Dec;27(12):2257-2261. doi: 10.1016/j.jse.2018.07.034. Epub 2018 Oct 16.

PMID:
30340926
15.

Modeling Undetected Live Poliovirus Circulation After Apparent Interruption of Transmission: Pakistan and Afghanistan.

Kalkowska DA, Duintjer Tebbens RJ, Pallansch MA, Thompson KM.

Risk Anal. 2019 Feb;39(2):402-413. doi: 10.1111/risa.13214. Epub 2018 Oct 8.

PMID:
30296340
16.

An essential Staphylococcus aureus cell division protein directly regulates FtsZ dynamics.

Eswara PJ, Brzozowski RS, Viola MG, Graham G, Spanoudis C, Trebino C, Jha J, Aubee JI, Thompson KM, Camberg JL, Ramamurthi KS.

Elife. 2018 Oct 2;7. pii: e38856. doi: 10.7554/eLife.38856.

17.

Evaluation of Proactive and Reactive Strategies for Polio Eradication Activities in Pakistan and Afghanistan.

Duintjer Tebbens RJ, Thompson KM.

Risk Anal. 2019 Feb;39(2):389-401. doi: 10.1111/risa.13194. Epub 2018 Sep 21.

PMID:
30239026
18.

Environmental Surveillance System Characteristics and Impacts on Confidence About No Undetected Serotype 1 Wild Poliovirus Circulation.

Kalkowska DA, Duintjer Tebbens RJ, Thompson KM.

Risk Anal. 2019 Feb;39(2):414-425. doi: 10.1111/risa.13193. Epub 2018 Sep 21.

PMID:
30239023
19.

Preoperative Narcotic Use and Inferior Outcomes After Anatomic Total Shoulder Arthroplasty: A Clinical and Radiographic Analysis.

Thompson KM, Hallock JD, Smith RA, Brolin TJ, Azar FM, Throckmorton TW.

J Am Acad Orthop Surg. 2019 Mar 1;27(5):177-182. doi: 10.5435/JAAOS-D-16-00808.

PMID:
30192247
20.

Idiopathic cervical tracheal stenosis in an 11-year-old male.

Hoffman MR, Thompson KM, Van Beek-King J.

Int J Pediatr Otorhinolaryngol. 2018 Oct;113:72-75. doi: 10.1016/j.ijporl.2018.05.013. Epub 2018 Jul 25.

PMID:
30174014
21.

Current and past depressive symptoms and contraceptive effectiveness level method selected among women seeking reproductive health services.

Steinberg JR, Adler NE, Thompson KM, Westhoff C, Harper CC.

Soc Sci Med. 2018 Oct;214:20-25. doi: 10.1016/j.socscimed.2018.08.009. Epub 2018 Aug 13. Erratum in: Soc Sci Med. 2019 Jan;220:440.

PMID:
30138841
22.

Polio endgame risks and the possibility of restarting the use of oral poliovirus vaccine.

Duintjer Tebbens RJ, Thompson KM.

Expert Rev Vaccines. 2018 Aug;17(8):739-751. doi: 10.1080/14760584.2018.1506333. Epub 2018 Aug 9. Review.

23.

Testing a novel isokinetic dynamometer constructed using a 1080 Quantum.

Whinton AK, Thompson KMA, Power GA, Burr JF.

PLoS One. 2018 Jul 20;13(7):e0201179. doi: 10.1371/journal.pone.0201179. eCollection 2018.

24.

Systematic review of the incremental costs of interventions that increase immunization coverage.

Ozawa S, Yemeke TT, Thompson KM.

Vaccine. 2018 Jun 14;36(25):3641-3649. doi: 10.1016/j.vaccine.2018.05.030. Epub 2018 May 10. Review.

PMID:
29754699
25.

Planning for globally coordinated cessation of bivalent oral poliovirus vaccine: risks of non-synchronous cessation and unauthorized oral poliovirus vaccine use.

Duintjer Tebbens RJ, Hampton LM, Thompson KM.

BMC Infect Dis. 2018 Apr 10;18(1):165. doi: 10.1186/s12879-018-3074-0.

26.

Training contraceptive providers to offer intrauterine devices and implants in contraceptive care: a cluster randomized trial.

Thompson KMJ, Rocca CH, Stern L, Morfesis J, Goodman S, Steinauer J, Harper CC.

Am J Obstet Gynecol. 2018 Jun;218(6):597.e1-597.e7. doi: 10.1016/j.ajog.2018.03.016. Epub 2018 Mar 23.

27.

Moderate Load Resisted Sprints do Not Improve Subsequent Sprint Performance in Varsity Level Sprinters.

Thompson KMA, Whinton AK, Ferth S, Spriet LL, Burr JF.

J Strength Cond Res. 2018 Mar 22. doi: 10.1519/JSC.0000000000002524. [Epub ahead of print]

PMID:
29570579
28.

Atraumatic Clostridial Myonecrosis in an Immunocompromised Host.

Thompson KM, Kruse BT, Hedges MAS.

J Emerg Med. 2018 Jun;54(6):e121-e123. doi: 10.1016/j.jemermed.2018.01.036. Epub 2018 Mar 10.

PMID:
29534840
29.

The Shock of Strep: Rapid Deaths Due to Group a Streptococcus.

Thompson KM, Sterkel AK, McBride JA, Corliss RF.

Acad Forensic Pathol. 2018 Mar;8(1):136-149. doi: 10.23907/2018.010. Epub 2018 Mar 7. Review.

30.

Key steps forward for maternal immunization: Policy making in action.

Beigi RH, Omer SB, Thompson KM.

Vaccine. 2018 Mar 14;36(12):1521-1523. doi: 10.1016/j.vaccine.2018.02.041. Epub 2018 Feb 16. No abstract available.

PMID:
29456018
31.

The National Vaccine Advisory Committee at 30: Impact and opportunity.

Thompson KM, Gellin BG, Hinman AR, Orenstein WA.

Vaccine. 2018 Mar 7;36(11):1330-1344. doi: 10.1016/j.vaccine.2018.01.068. Review.

PMID:
29422369
32.

Ischemic Preconditioning: No Influence on Maximal Sprint Acceleration Performance.

Thompson KMA, Whinton AK, Ferth S, Spriet LL, Burr JF.

Int J Sports Physiol Perform. 2018 Sep 1;13(8):986-990. doi: 10.1123/ijspp.2017-0540. Epub 2018 Sep 9.

PMID:
29345532
33.

Modeling Poliovirus Transmission in Pakistan and Afghanistan to Inform Vaccination Strategies in Undervaccinated Subpopulations.

Duintjer Tebbens RJ, Pallansch MA, Cochi SL, Ehrhardt DT, Farag NH, Hadler SC, Hampton LM, Martinez M, Wassilak SGF, Thompson KM.

Risk Anal. 2018 Aug;38(8):1701-1717. doi: 10.1111/risa.12962. Epub 2018 Jan 3.

PMID:
29314143
34.

Low Vs. High Alcohol: Central Benefits Vs. Detriments.

Tizabi Y, Getachew B, Ferguson CL, Csoka AB, Thompson KM, Gomez-Paz A, Ruda-Kucerova J, Taylor RE.

Neurotox Res. 2018 Nov;34(4):860-869. doi: 10.1007/s12640-017-9859-x. Epub 2018 Jan 4. Review.

PMID:
29302849
35.

Risks of Exertional Rhabdomyolysis With Blood Flow-Restricted Training: Beyond the Case Report.

Thompson KMA, Slysz JT, Burr JF.

Clin J Sport Med. 2018 Nov;28(6):491-492. doi: 10.1097/JSM.0000000000000488. No abstract available.

PMID:
29084035
36.

Experimental and theoretical studies of the reactions of ground-state sulfur atoms with hydrogen and deuterium.

Thompson KM, Gao Y, Marshall P, Wang H, Zhou L, Li Y, Guo H.

J Chem Phys. 2017 Oct 7;147(13):134302. doi: 10.1063/1.4991418.

PMID:
28987091
37.

Contraception after medication abortion in the United States: results from a cluster randomized trial.

Rocca CH, Goodman S, Grossman D, Cadwallader K, Thompson KMJ, Talmont E, Speidel JJ, Harper CC.

Am J Obstet Gynecol. 2018 Jan;218(1):107.e1-107.e8. doi: 10.1016/j.ajog.2017.09.020. Epub 2017 Oct 3.

38.

Lessons From Globally Coordinated Cessation of Serotype 2 Oral Poliovirus Vaccine for the Remaining Serotypes.

Thompson KM, Duintjer Tebbens RJ.

J Infect Dis. 2017 Jul 1;216(suppl_1):S168-S175. doi: 10.1093/infdis/jix128.

39.

Lessons From the Polio Endgame: Overcoming the Failure to Vaccinate and the Role of Subpopulations in Maintaining Transmission.

Thompson KM, Duintjer Tebbens RJ.

J Infect Dis. 2017 Jul 1;216(suppl_1):S176-S182. doi: 10.1093/infdis/jix108.

40.

What will it take to end human suffering from measles?

Thompson KM.

Lancet Infect Dis. 2017 Oct;17(10):1013-1014. doi: 10.1016/S1473-3099(17)30451-6. Epub 2017 Aug 11. No abstract available.

PMID:
28807626
41.

Insights from a Systematic Search for Information on Designs, Costs, and Effectiveness of Poliovirus Environmental Surveillance Systems.

Duintjer Tebbens RJ, Zimmermann M, Pallansch MA, Thompson KM.

Food Environ Virol. 2017 Dec;9(4):361-382. doi: 10.1007/s12560-017-9314-4. Epub 2017 Jul 7. Review.

PMID:
28687986
42.

Modeling the costs and benefits of temporary recommendations for poliovirus exporting countries to vaccinate international travelers.

Duintjer Tebbens RJ, Thompson KM.

Vaccine. 2017 Jul 5;35(31):3823-3833. doi: 10.1016/j.vaccine.2017.05.090. Epub 2017 Jun 9.

43.

Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.

Thompson KM, Badizadegan ND.

Risk Anal. 2017 Jun;37(6):1109-1131. doi: 10.1111/risa.12831. Epub 2017 May 31.

PMID:
28561947
44.

Modeling and Managing the Risks of Measles and Rubella: A Global Perspective Part II.

Thompson KM.

Risk Anal. 2017 Jun;37(6):1041-1051. doi: 10.1111/risa.12823. Epub 2017 May 4.

PMID:
28471528
45.

TrmL and TusA Are Necessary for rpoS and MiaA Is Required for hfq Expression in Escherichia coli.

Aubee JI, Olu M, Thompson KM.

Biomolecules. 2017 May 4;7(2). pii: E39. doi: 10.3390/biom7020039.

46.

A multidisciplinary approach to reducing alarm fatigue and cost through appropriate use of cardiac telemetry.

Alsaad AA, Alman CR, Thompson KM, Park SH, Monteau RE, Maniaci MJ.

Postgrad Med J. 2017 Jul;93(1101):430-435. doi: 10.1136/postgradmedj-2016-134764. Epub 2017 Apr 28.

PMID:
28455284
47.

Poliovirus vaccination during the endgame: insights from integrated modeling.

Duintjer Tebbens RJ, Thompson KM.

Expert Rev Vaccines. 2017 Jun;16(6):577-586. doi: 10.1080/14760584.2017.1322514. Epub 2017 May 9. Review.

PMID:
28437234
48.

Chronic heat exposure for health and exercise performance - cardiovascular research heats up.

Thompson KMA, Coates AM, Incognito AV, Whinton AK.

J Physiol. 2017 Jul 1;595(13):4137-4138. doi: 10.1113/JP274003. Epub 2017 May 14. No abstract available.

49.

Looking Under the Streetlight? A Framework for Differentiating Performance Measures by Level of Care in a Value-Based Payment Environment.

Naessens JM, Van Such MB, Nesse RE, Dilling JA, Swensen SJ, Thompson KM, Orlowski JM, Santrach PJ.

Acad Med. 2017 Jul;92(7):943-950. doi: 10.1097/ACM.0000000000001654.

50.

Using PAs in prehospital environments to reduce ED and EMS overuse.

Thompson KM, Tozier WL.

JAAPA. 2017 Apr;30(4):49-52. doi: 10.1097/01.JAA.0000513350.53148.25.

PMID:
28350733

Supplemental Content

Loading ...
Support Center